{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:03:08Z","timestamp":1789588988238,"version":"build-2803163510"},"reference-count":26,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Public Health Surveill"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Surveillance of tuberculosis (TB) is challenging given the typically long course of the disease and treatment as well as the often complex socioeconomic factors that are associated with it. In Spain, surveillance is decentralized across autonomous communities (CCAAs), leading to additional challenges in heterogeneity and data quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to quantify changes in internal data completeness following introduction of annual regional surveillance quality reports and assess the acceptability and perceived usefulness among CCAAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This mixed methods assessment consisted of 2 stages. First, we quantitatively assessed the internal completeness of 40 key TB variables for all reported cases from 2018 to 2023, comparing 2 periods: before (2018\u20102020) and after (2021\u20102023) the implementation of feedback reports. Mean completeness for each variable was calculated for each period, and the differences were compared using either the paired\n                      <jats:italic>t<\/jats:italic>\n                      test or Wilcoxon signed rank test depending on whether differences were normally distributed. Analyses were conducted nationally and by CCAA as well as for different variable groups (patient-, illness-, and laboratory-related groups). For the second stage, we circulated the results to regional TB surveillance focal points, along with a survey to assess acceptability, perceived usefulness of reports, and barriers to data completeness.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 25,229 reported cases across the study period: 13,328 in period 1 (2018\u20102020) and 11,901 in period 2 (2021\u20102023). Nationally, mean completeness increased from 66% in period 1 to 76.2% in period 2 (+10.2%,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001). Improvements were greatest for laboratory-related (+13.9%,\n                      <jats:italic>P<\/jats:italic>\n                      =.001) and illness-related variables (+12.8%,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001), while patient-related variables showed minimal change that was not statistically significant (+2.4%,\n                      <jats:italic>P<\/jats:italic>\n                      =.48). Most CCAAs (16\/19, 84%) demonstrated improved completeness in period 2, though substantial regional variation persisted. Of the 19 CCAAs, 18 responded to the survey. Respondents reported high acceptability of the surveillance system and considered feedback reports useful. Challenges included resource constraints, system interoperability between laboratory and surveillance, and patient follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Following the introduction of annual feedback reports, which were well accepted by all regional stakeholders, Spain saw significant improvements in TB data completeness. Sustained feedback mechanisms, streamlined reporting requirements, and improved integration between epidemiological and laboratory systems are key to strengthening TB surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/93719","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:11:26Z","timestamp":1789585886000},"page":"e93719-e93719","source":"Crossref","is-referenced-by-count":0,"title":["Data Completeness and Acceptability of Annual Feedback Reports and Tuberculosis Surveillance in Spain, 2018-2024: Mixed Methods Analysis"],"prefix":"10.2196","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5120-4225","authenticated-orcid":false,"given":"Allegra","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1436-8012","authenticated-orcid":false,"given":"Alvaro","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4481-1302","authenticated-orcid":false,"given":"Rocio","family":"Amillategui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2928-2840","authenticated-orcid":false,"given":"Mar\u00eda","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1829-8875","authenticated-orcid":false,"given":"Christine","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7132-6348","authenticated-orcid":false,"given":"Rosa","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2196-6109","authenticated-orcid":false,"given":"Laura","family":"Herrera-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6508-3818","authenticated-orcid":false,"given":"Zaida","family":"Herrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Spanish Working Group on Tuberculosis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"12","key":"R1","doi-asserted-by":"publisher","first-page":"101044","DOI":"10.1016\/j.lanmic.2024.101044","article-title":"Despite available tools tuberculosis is the top killer again","volume":"5","author":"The Lancet Microbe","journal-title":"Lancet Microbe"},{"key":"R2","unstructured":"Global tuberculosis report 2025. World Health Organization; 2025. URL: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025 [Accessed 21-08-2026]"},{"key":"R3","unstructured":"The end TB strategy. The World Health Organization (WHO); 2014. URL: https:\/\/www.who.int\/publications\/i\/item\/WHO-HTM-TB-2015.19 [Accessed 21-08-2026]"},{"key":"R4","unstructured":"Tuberculosis surveillance and monitoring in Europe 2026: 2024 data. World Health Organization; 2026. URL: https:\/\/www.who.int\/europe\/publications\/i\/item\/9789289062879 [Accessed 21-08-2026]"},{"issue":"3","key":"R5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1183\/09031936.00030612","article-title":"Tuberculosis treatment outcome monitoring in European Union countries: systematic review","volume":"41","author":"van Hest","journal-title":"Eur Respir J"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-020-00072-5","article-title":"Tuberculosis in migrants - screening, surveillance and ethics","volume":"12","author":"Scandurra","journal-title":"Pneumonia (Nathan)"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295918","article-title":"The epidemiological situation of tuberculosis in Spain according to surveillance and hospitalization data, 2012-2020","volume":"19","author":"Pedraz","journal-title":"PLOS ONE"},{"key":"R8","unstructured":"Vigilancia de la tuberculosis a\u00f1o 2024: resultados de la Red Nacional de Vigilancia Epidemiol\u00f3gica. Ministerio de Ciencia, Innovacion y Universidades, Centro Nacional de Epidemiolog\u00eda; 2024. URL: https:\/\/cne.isciii.es\/documents\/d\/cne\/renave_informe_vigilancia-tb_-2024 [Accessed 21-08-2026]"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2026.2656557","article-title":"Epidemiological characteristics and trends of paediatric tuberculosis cases in Spain, 2012-2023","volume":"58","author":"Fontana Campos","journal-title":"Ann Med"},{"key":"R10","unstructured":"Protocolo de vigilancia de tuberculosis. Centro Nacional de Epidemiologia; URL: https:\/\/cne.isciii.es\/documents\/d\/cne\/protocolo-20de-20vigilancia-20de-20tuberculosis-pdf [Accessed 21-08-2026]"},{"key":"R11","unstructured":"Data quality monitoring and surveillance system evaluation: a handbook of methods and applications. European Centre for Disease Prevention and Control; 2014. URL: https:\/\/data.europa.eu\/doi\/10.2900\/35329 [Accessed 21-08-2026]"},{"key":"R12","unstructured":"European Centre for Disease Prevention and ControlWorld Health Organization. Tuberculosis surveillance and monitoring in europe 2025: 2023 data. European Union; 2025. URL: https:\/\/data.europa.eu\/doi\/10.2900\/2650058 [Accessed 21-08-2026]"},{"key":"R13","unstructured":"WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment: web annexes. World Health Organization; 2022. URL: https:\/\/iris.who.int\/items\/b9dde581-515d-4283-94a1-f3f99125700a [Accessed 21-08-2026]"},{"issue":"4","key":"R14","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","journal-title":"Eur Respir J"},{"issue":"6","key":"R15","doi-asserted-by":"publisher","first-page":"624","DOI":"10.5588\/ijtld.16.0845","article-title":"Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points","volume":"21","author":"L\u00f6nnroth","journal-title":"Int J Tuberc Lung Dis"},{"key":"R16","unstructured":"Hargreaves S Rustage K Nellums LB et al. What Constitutes an Effective and Efficient Package of Services for the Prevention, Diagnosis, Treatment and Care of Tuberculosis among Refugees and Migrants in the WHO European Region? Themed Issues on Migration and Health, VIII. WHO Regional Office for Europe; 2018. URL: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519087"},{"key":"R17","unstructured":"Gavald\u00e0 Mestre L L\u00f3pez Espinilla M Mart\u00ednez Alguacil H Medina Maestro S Sicart Torres E . Situaci\u00f3 epidemiol\u00f2gica i tend\u00e8ncia de l\u2019end\u00e8mia tuberculosa a Catalunya - 2023. Subdirecci\u00f3 General de Vigil\u00e0ncia i Resposta a Emerg\u00e8ncies de Salut P\u00fablica; Feb 2025. URL: https:\/\/scientiasalut.gencat.cat\/handle\/11351\/12767 [Accessed 09-01-2026]"},{"issue":"1","key":"R18","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es2014.19.1.20667","article-title":"The Danish Microbiology Database (MiBa) 2010 to 2013","volume":"19","author":"Voldstedlund","journal-title":"Euro Surveill"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2807\/esm.10.01.00513-en","article-title":"Electronic reporting improves timeliness and completeness of infectious disease notification, The Netherlands, 2003","volume":"10","author":"Ward","journal-title":"Euro Surveill"},{"issue":"6","key":"R20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1136\/thorax.57.6.477","article-title":"Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999","volume":"57","author":"Djuretic","journal-title":"Thorax"},{"issue":"S-5","key":"R21","first-page":"1","volume":"37","author":"Klaucke","journal-title":"MMWR"},{"issue":"5","key":"R22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.puhe.2015.02.015","article-title":"Assessment of timeliness, representativeness and quality of data reported to Italy\u2019s national integrated surveillance system for acute viral hepatitis (SEIEVA)","volume":"129","author":"Tosti","journal-title":"Public Health"},{"key":"R23","unstructured":"Consolidated guidance on tuberculosis data generation and use module 1 tuberculosis surveillance. World Health Organization; 2024. URL: https:\/\/www.who.int\/publications\/i\/item\/9789240075290 [Accessed 21-08-2026]"},{"key":"R24","unstructured":"The European Centre for Disease Prevention and Control (ECDC). International tuberculosis care transfer form. Sep 29, 2025. URL: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/international-tuberculosis-care-transfer-form [Accessed 27-10-2025]"},{"issue":"1","key":"R25","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1791-5","article-title":"Surveillance systems evaluation: a systematic review of the existing approaches","volume":"15","author":"Calba","journal-title":"BMC Public Health"},{"key":"R26","unstructured":"Contact. Centro Nacional de Epidemiolog\u00eda, ISCIII. URL: https:\/\/cne.isciii.es\/en\/contact [Accessed 21-08-2026]"}],"container-title":["JMIR Public Health and Surveillance"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:11:32Z","timestamp":1789585892000},"score":1,"resource":{"primary":{"URL":"https:\/\/publichealth.jmir.org\/2026\/1\/e93719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":26,"URL":"https:\/\/doi.org\/10.2196\/93719","relation":{},"ISSN":["2369-2960"],"issn-type":[{"value":"2369-2960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"v12i12e93719"}}